SEC 13F Intelligence

Euclidean Technologies Management, LLC / MED

Euclidean Technologies Management, LLC’s Medifast Inc Position

Does Euclidean Technologies Management, LLC own Medifast Inc (MED)? Not currently — the last reported position was 17.0K shares worth $4M in Q1 2021; the fund’s latest 13F (Q1 2023) no longer reports it.

Position Value
$4M
Q1 2021
Shares
17.0K
% of Portfolio
+3.13%
Quarters Held
4
position exited

Position History MED

Reported value by quarter
Q2 ’20: $2MQ2 ’20Q3 ’20: $3MQ3 ’20Q4 ’20: $3MQ4 ’20Q1 ’21: $4MQ1 ’21filingsflow.com
QuarterSharesValue% of Portfolio
Q1 202117.0K$4M+3.13%
Q4 202017.0K$3M+3.51%
Q3 202017.0K$3M+3.52%
Q2 202017.0K$2M+3.31%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Euclidean Technologies Management, LLC’s full portfolio or all institutional holders of MED.